耐火材料（行星科学）
威罗菲尼
甲状腺癌
医学
碘
癌症研究
甲状腺
癌症
放射性碘
甲状腺乳突癌
不利影响
肿瘤科
内科学
药品
药理学
化学
生物
有机化学
转移性黑色素瘤
天体生物学
出处
期刊：Cancer Discovery
[American Association for Cancer Research]
日期：2016-10-01
卷期号：6 (10): OF4-OF4
标识
DOI：10.1158/2159-8290.cd-nb2016-105
摘要
A new study shows that the BRAF inhibitor vemurafenib may induce partial responses and stable disease in patients with papillary thyroid cancer that has become refractory to radioactive iodine. However, the drug led to a variety of serious adverse events in roughly 65% of patients, including the development of some squamous cell carcinomas.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
Twonej
蓝莓橘子酱
你嵙这个期刊没买
贪玩的秋柔
gyh
Dean
GingerF
BowieHuang
zhonglv7
Stella
111
大力的灵雁
舒心宛菡
davincimmk
pluto
干净的琦
SONGYEZI
热心市民小红花
橘x
皖公网安备34019202002308
